Prolonged curarisation in the presence of renal failure occurred in six cases where pancuronium was used, and one case where alcuronium was used. The cases are presented with a brief review of the literature.
Pancuronium must be used with great caution if postoperative reversal problems are to be avoided. Greater use of adjuvants will reduce requirements and may eliminate the problems encountered in renal failure.
References
1.
AbramsR. E., and HornbeinT. F. (1975): “Inability to reverse pancuronium blockade in a patient with renal failure and hepatic disease”, Anesthesiology, 42, 362.
2.
AgostonS., KerstenU. W., and MeijerD. K. F. (1973): “The fate of pancuronium bromide in the cat”. Acta Anaesth. Scand., 17, 129.
3.
Churchill-DavidsonR. C., WayW. L., and deJongR. H. (1967): “The muscle relaxants and renal excretion”. Anesthesiology, 28, 540.
4.
CohenE. N., BrewerH. W., and SmithD. (1967): The metabolism and elements of dtc H3, Anesthesiology.28, 309.
5.
FeldmanS. A. (1973): “Muscle Relaxants”.W. B. Saunders Company Ltd., London.
6.
GibaldiM., LevyG., and HaytonW. L. (1972): “Tubocurarine and renal failure”. Brit. J. Anaesth., 44, 163.
7.
HunterA. R. (1976): “New Drugs”. Recent Advances in Anaesthesia and Analgesia.Churchill-Livingstone. Edinburgh. London.
8.
Kamvyssi-DeaK., PapadimitriouiK., and DousaitouP. (1972): “The use of pancuronium bromide in operations for renal insufficiency”, Brit. J. Anaesth., 44, 1217.
9.
KatzJ., KountzS. L., and CohnR. (1967): “Anaesthetic considerations for renal transplant”. Anesth. Analg. Curr. Res., 46, 609.
10.
McLeodK., WatsonM. J., and RawlinsM. D. (1975): “Plasma concentrations of pancuronium bromide in patients with normal and impaired renal function”. Brit. J. Anaesth., 47, 902.
11.
MillerR. D., and CullenD. J. (1976): “Renal failure and post operative respiratory failure: recurarisation?”, Brit. J. Anaesth., 48, 253.
12.
MonksP. S., and LumleyJ. (1972): “Anaesthetic aspects of renal transplantation”. Ann. Row Coll. Surg. Eng., 50, 354.
13.
NormanJ., KatzR. L., and SeedR. F. (1970): “The neuromuscular blocking action of pancuronium in man during anaesthesia”. Brit. J. Anaesth., 42, 702.
14.
RiordanD. D., and GilbertsonA. A. (1971): “Prolonged curarisation in a patient with renal failure”. Brit. J. Anaesth., 43, 506.
15.
RouseJ. M., GalleyR. L. A., and BevanD. R. (1977): “Prolonged curarisation following renal transplantation”. Anaesthesia, 32, 247.
16.
SamuelJ. R., and PowellD. (1970): “Renal transplantation. Anaesthetic experience in 100 cases”, Anaesthesia, 25, 165.
17.
SlawsonK. B. (1972): “Anaesthesia for the patient in renal failure”, Brit. J. Anaesth., 44, 277.
18.
SpeirsI., and SimA. W. (1972): “The placental transfer of pancuronium bromide”, Brit. J. Anaesth., 44, 370.
19.
StovnerJ., TheodorsenL., and BjelkeE. (1972): “Sensitivity to dimethyl tubocurarine and toxiferine with special reference to serum proteins”. Brit. J. Anaesth., 44, 374.
20.
StruninL., StruninJ. M., and LaytonJ. (1972): “Metabolism of 14 — pancuronium bromide by the isolated perfused canine liver”, Brit. J. Anaesth., 44, 624.
21.
WhiteR. D., De WeerdJ. H., and DawsonB. (1971): “Gallamine in anaesthesia for patients with chronic renal failure undergoing bilateral nephrectomy”, Anesth. Analg. Curr. Res., 50, 11.
